Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000731035 | SCV000858805 | uncertain significance | not provided | 2017-12-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001241260 | SCV001414266 | likely benign | Duchenne muscular dystrophy | 2025-01-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002321730 | SCV002609629 | uncertain significance | Cardiovascular phenotype | 2020-07-28 | criteria provided, single submitter | clinical testing | The p.M1064T variant (also known as c.3191T>C), located in coding exon 24 of the DMD gene, results from a T to C substitution at nucleotide position 3191. The methionine at codon 1064 is replaced by threonine, an amino acid with similar properties. Based on data from gnomAD, the C allele has an overall frequency of 0.003% (6/205056) total alleles studied, including one hemizygote. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001827985 | SCV002088976 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2018-08-31 | no assertion criteria provided | clinical testing |